Alan L. Epstein

11.4k citations

204 papers · 9.1k indexed · 1 hit paper · h-index 51

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Radiology, Nuclear Medicine and Imaging 95
- Monoclonal and Polyclonal Antibodies Research 80
- Radiopharmaceutical Chemistry and Applications 33
Immunology 77
- Immunotherapy and Immune Responses 36
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 19

Co-authors: Melissa G. Lechner Leslie A. Khawli Peisheng Hu Henry S. Kaplan Charles V. Clevenger P Goldman Jane P. Jensen Ajay Bakhshi
Journals: Clinical Cancer Research (10 papers)Cancer (9 papers)The Journal of Immunology (7 papers)Journal of Immunotherapy (7 papers)Cancer Biotherapy and Radiopharmaceuticals (7 papers)
Partner nations: United States China Italy

In The Last Decade

Alan L. Epstein

203 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 1985 · 974 citations

Peers

Countries citing papers authored by Alan L. Epstein

Since Specialization

Citations

This map shows the geographic impact of Alan L. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan L. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan L. Epstein more than expected).

Fields of papers citing papers by Alan L. Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan L. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan L. Epstein. The network helps show where Alan L. Epstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan L. Epstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan L. Epstein Line = papers co-authored together Alan L. Epstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2 Cancers ·Griffin Egner, Fiorella Di Nicuolo, Giada Bianchetti, Alan L. Epstein, Giuseppe Grande, Giuseppe Maulucci, Marco De Spirito, Alfredo Pontecorvi, Domenico Milardi, Francesca Mancini	2021	13
2	A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models Clinical Cancer Research ·Long Zheng, R. Michael Smart, Jani Setiawati Natalia, Leslie A. Khawli, Peisheng Hu, Harvey R. Kaslow, Alan L. Epstein	2020	29
3	Evidence That Some Breast Implant Associated Anaplastic Large Cell Lymphomas Arise in the Context of Allergic Inflammation Blood ·Marshall E. Kadin, Alan L. Epstein, William P. Adams, Caroline Glicksman, David A. Sieber, Bradley Hubbard, L. Jeffrey Medeiros, Mark W. Clemens, Roberto N. Miranda	2017	7
4	MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro Clinical Cancer Research ·Trevor E. Angell, Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, Alan L. Epstein	2014	120
5	An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas Clinical Cancer Research ·Katherine A. Murphy, Melissa G. Lechner, Flavia E. Popescu, Matthew Campora, Stacy A. Decker, Peisheng Hu, Jami R. Erickson, 原樹稲束, R. M. Lindvall, Andres Μ. Salazar, Michael R. Olin, Alan L. Epstein, John R. Ohlfest	2012	29
6	Generation of tumor-targeted antibody–CpG conjugates Journal of Immunological Methods ·Zhongjun Li, Julie K. Jang, Melissa G. Lechner, Peisheng Hu, Leslie A. Khawli, Christopher A. Scannell, Alan L. Epstein	2012	12
7	A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment Cancer Research ·Angela D. Pardee, Dustin McCurry, Sean Alber, Peisheng Hu, Alan L. Epstein, Walter J. Storkus	2010	38
8	Target-Dependent B7-H1 Regulation Contributes to Clearance of Central Nervous Sysyem Infection and Dampens Morbidity The Journal of Immunology ·Timothy W. Phares, Chandran Ramakrishna, Gabriel I. Parra, Alan L. Epstein, Lieping Chen, Roscoe Atkinson, Stephen A. Stohlman, Cornelia C. Bergmann	2009	58
9	RA8, A Human Anti-CD25 Antibody Against Human Treg Cells Hybridoma ·D. Gomes, M. FLANAGAN, Keith Miller, Awamura Tsutomu, Peisheng Hu, J.M. Vorster, Leslie A. Khawli, Alan L. Epstein	2007	2
10	Lym-1-Induced Apoptosis of Non-Hodgkin's Lymphomas Produces Regression of Transplanted Tumors Cancer Biotherapy and Radiopharmaceuticals ·Nan Zhang, Leslie A. Khawli, Peisheng Hu, Alan L. Epstein	2007	7
11	chTNT-3/hu IL-12 Fusion Protein for the Immunotherapy of Experimental Solid Tumors PubMed ·Jiali Li, Peisheng Hu, Leslie A. Khawli, M. Stiasny, Alan L. Epstein	2004	16
12	Comparison of Recombinant Derivatives of Chimeric TNT-3 Antibody for the Radioimaging of Solid Tumors PubMed ·Leslie A. Khawli, Barbara H. Biela, Peisheng Hu, Alan L. Epstein	2003	29
13	Chimeric TNT-3 Antibody/Murine Interferon- γ Fusion Protein for the Immunotherapy of Solid Malignancies PubMed ·HIROKO SONE, Peisheng Hu, Leslie A. Khawli, Jiali Li, Alan L. Epstein	2003	25
14	Chimeric TNT-3/Human β -Glucuronidase Fusion Proteins for Antibody-Directed Enzyme Prodrug Therapy (ADEPT) Cancer Biotherapy and Radiopharmaceuticals ·Barbara H. Biela, Leslie A. Khawli, Peisheng Hu, Alan L. Epstein	2003	19
15	Generation of Human Interferon Gamma and Tumor Necrosis Factor Alpha Chimeric TNT-3 Fusion Proteins PubMed ·Tomokazu Murayama, Leslie A. Khawli, Peisheng Hu, Bril J, Alan L. Epstein	2002	22
16	Stable, Genetically Engineered F(ab′) ₂ Fragments of Chimeric TNT-3 Expressed in Mammalian Cells PubMed ·Leslie A. Khawli, Barbara H. Biela, Peisheng Hu, Alan L. Epstein	2002	15
17	Diffusion and Binding of Monoclonal Antibody TNT-1 in Multicellular Tumor Spheroids JNCI Journal of the National Cancer Institute ·Li Luhao, Egon Bech Hansen, Curtis R. Taylor, Alan L. Epstein	1991	23
18	A Live Cell Enzyme-Linked Immunosorbent Assay for Detecting Human Hepatoma Membrane Antigens Hybridoma ·Janaira de Lima Guimarães, Zhen Li, Alan L. Epstein	1989	5
19	Short-Term Efficient Expression of Transfected DNA in Human Hematopoietic Cells by Electroporation: Definition of Parameters and Use of Chemical Stimulators DNA ·Daniel Boy, Alan L. Epstein	1988	11
20	¹²³ I Radiolabeling of Monoclonal Antibodies for In Vivo Procedures Hybridoma ·Sahera Khalaf, Sally J. DeNardo, Gerald L. DeNardo, Alan L. Epstein, Nadezhda Trendafilova, David Colcher	1986	7

About Alan L. Epstein

Alan L. Epstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Pathology and Forensic Medicine and Immunology and Allergy, having authored 204 papers that have together received 9.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (80 papers), Immunotherapy and Immune Responses (36 papers), Radiopharmaceutical Chemistry and Applications (33 papers), Lymphoma Diagnosis and Treatment (30 papers), Glycosylation and Glycoproteins Research (28 papers), Immune Cell Function and Interaction (26 papers), CAR-T cell therapy research (22 papers) and T-cell and B-cell Immunology (19 papers). The work is most often cited by research in Immunology (3.2k citations), Oncology (2.9k citations), Radiology, Nuclear Medicine and Imaging (2.2k citations), Pathology and Forensic Medicine (1.6k citations) and Cancer Research (1.0k citations). Alan L. Epstein has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Melissa G. Lechner, Leslie A. Khawli, Peisheng Hu, Henry S. Kaplan, Charles V. Clevenger, P Goldman, Jane P. Jensen, Ajay Bakhshi, Stanley J. Korsmeyer and James R. Wright. Their work appears in journals such as Clinical Cancer Research, Cancer, The Journal of Immunology, Journal of Immunotherapy and Cancer Biotherapy and Radiopharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact